Cargando…

EGFR mutations are significantly associated with visceral pleural invasion development in non-small-cell lung cancer patients

OBJECTIVES: A retrospective study was performed to investigate the association between EGFR mutations and visceral pleural invasion (VPI), and evaluate the prognostic value of EGFR in resected non-small-cell lung cancer (NSCLC) patients with VPI. MATERIALS AND METHODS: Clinicopathological characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jinghan, Yang, Yang, Zhao, Yanfeng, Zhu, Junjie, Song, Xiao, Jiang, Gening
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402433/ https://www.ncbi.nlm.nih.gov/pubmed/30881120 http://dx.doi.org/10.2147/CMAR.S195747

Ejemplares similares

Clinicopathological and Prognostic Significance of EML4-ALK Rearrangement in Patients with Surgically Resected Lung Adenocarcinoma: A Propensity Score Matching Study
por: Shi, Jinghan, et al.
Publicado: (2020)

The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma
por: Shi, Jinghan, et al.
Publicado: (2021)

Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively
por: Hu, Junjie, et al.
Publicado: (2021)

Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non‐small cell lung cancer
por: Wo, Yang, et al.
Publicado: (2019)

Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non‐small cell lung cancer
por: Tian, Dan, et al.
Publicado: (2017)

The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection
por: Choi, Si Young, et al.
Publicado: (2020)

Clinical And Imageological Features Of Lung Squamous Cell Carcinoma With EGFR Mutations
por: Gao, Xuejuan, et al.
Publicado: (2019)

Relative Low Glycometabolism May Also Occur in Invasive Lung Adenocarcinoma With Visceral Pleural Invasion: Case Report and Comments
por: Jiang, Chunyang, et al.
Publicado: (2014)

Extent of visceral pleural invasion and the prognosis of surgically resected node‐negative non‐small cell lung cancer
por: Seok, Yangki, et al.
Publicado: (2017)

Nomogram for Predicting the Relationship between the Extent of Visceral Pleural Invasion and Survival in Non-Small-Cell Lung Cancer
por: Wang, Fan, et al.
Publicado: (2021)

Clinical characteristics and establishment of a 2-year-OS predictive model of EGFR mutation-positive patients with pleural invasion of lung adenocarcinoma
por: Kong, Qing, et al.
Publicado: (2023)

Predictive value of SUVmax in visceral pleural invasive lung adenocarcinoma with different diameters
por: Sun, Xiaoyan, et al.
Publicado: (2023)

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
por: Yang, Jiyoul, et al.
Publicado: (2018)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
por: Gao, Xuejuan, et al.
Publicado: (2019)

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size
por: Huang, Weijia, et al.
Publicado: (2022)

Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development
por: Shi, Jinghan, et al.
Publicado: (2021)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012)

The Correlation between EGFR Mutation Status and DNA Content of Lung Adenocarcinoma Cells in Pleural Effusion
por: Du, Yun, et al.
Publicado: (2020)

Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis
por: Wang, Ting, et al.
Publicado: (2017)

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma
por: Liu, Dan, et al.
Publicado: (2014)

Diagnosis of visceral pleural invasion using confocal laser endomicroscopy during lung cancer surgery
por: Sawada, Toru, et al.
Publicado: (2021)

Carcinoembryonic antigen in pleural effusion of patients with lung adenocarcinoma: a predictive marker for EGFR mutation
por: Lv, Yan-Ling, et al.
Publicado: (2019)

Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS
por: Yang, Jie, et al.
Publicado: (2016)

Visceral pleural invasion predict a poor survival among lung adenocarcinoma patients with tumor size ≤ 3cm
por: Chen, Tianxiang, et al.
Publicado: (2017)

EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia
por: Vukovic, Miodrag, et al.
Publicado: (2023)

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study
por: Bian, Dongliang, et al.
Publicado: (2023)

Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer
por: Masuda, Takeshi, et al.
Publicado: (2023)

Rethinking the Selection of Pathological T-Classification for Non-Small-Cell Lung Cancer in Varying Degrees of Visceral Pleural Invasion: A SEER-Based Study
por: Fang, Pu, et al.
Publicado: (2022)

The prognosis of stage I non-small cell lung cancer with visceral pleural invasion and whole pleural adhesion after video-assisted thoracoscopic lobectomy: A single center retrospective study
por: Moon, Youngkyu, et al.
Publicado: (2020)

Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer
por: Ho, Ying Swan, et al.
Publicado: (2016)

Prognostic Impact of the Findings on Thin-Section Computed Tomography in stage I lung adenocarcinoma with visceral pleural invasion
por: Yuan, Mei, et al.
Publicado: (2018)

A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma
por: Zha, Xinyi, et al.
Publicado: (2022)

The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy
por: Canale, Matteo, et al.
Publicado: (2022)

Detecting EGFR mutations and ALK/ROS1 rearrangements in non‐small cell lung cancer using malignant pleural effusion samples
por: Yao, Yi, et al.
Publicado: (2018)

Correlations between EGFR gene polymorphisms and pleural metastasis of lung adenocarcinoma
por: Guo, Haisheng, et al.
Publicado: (2016)

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer
por: Bai, Hua, et al.
Publicado: (2013)

Prognostic Impact of EGFR Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor
por: Chinchilla-Tábora, Luís Miguel, et al.
Publicado: (2022)

Elderly male smokers with right lung tumors are viable candidates for KRAS mutation screening
por: Yang, Yang, et al.
Publicado: (2016)

Visceral pleural biopsy under medical thoracoscopy for the diagnosis of lung adenocarcinoma
por: Terashita, Satoshi, et al.
Publicado: (2020)

Pleural effusion as a substitute for tumor tissue in detecting EGFR/ALK mutations in non-small cell lung cancer: A systematic review and meta-analysis
por: Pang, Caishuang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_82asckprn95a9olbkimrm4poa6